The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes

Congenital myasthenic syndromes (CMS) are genetic disorders characterised by impaired neuromuscular transmission. This review provides an overview on CMS and highlights recent advances in the field, including novel CMS causative genes and improved therapeutic strategies. CMS due to mutations in SLC5...

Detaylı Bibliyografya
Asıl Yazarlar:	Rodríguez Cruz, P, Palace, J, Beeson, D
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	MDPI 2018

Benzer Materyaller

Congenital myasthenic syndromes and the neuromuscular junction.
Yazar:: Cruz, P, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
Yazar:: Beeson, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
Yazar:: Beeson, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
Yazar:: Beeson, D
Baskı/Yayın Bilgisi: (2008)

The congenital myasthenic syndromes.
Yazar:: Palace, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Congenital myasthenic syndromes.
Yazar:: Beeson, D, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Congenital myasthenic syndromes: an update.
Yazar:: Finlayson, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
Yazar:: Xufeng Liao, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
Yazar:: Cossins, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Therapeutic strategies for congenital myasthenic syndromes
Yazar:: Lee, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
Yazar:: Healy, E, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
Yazar:: Lashley, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Inherited disorders of the neuromuscular junction: an update.
Yazar:: Rodríguez Cruz, P, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
Yazar:: Man, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
Yazar:: Lashley, D, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Synaptic dysfunction in congenital myasthenic syndromes.
Yazar:: Beeson, D
Baskı/Yayın Bilgisi: (2012)

Congenital myasthenic syndromes: recent advances
Yazar:: Beeson, D
Baskı/Yayın Bilgisi: (2016)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
Yazar:: Burke, G, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

DOK7 congenital myasthenic syndrome.
Yazar:: Palace, J
Baskı/Yayın Bilgisi: (2012)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
Yazar:: Vincent, A, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
Yazar:: Vincent, A, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
Yazar:: Finlayson, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Animal models of the neuromuscular junction, vitally informative for understanding function and the molecular mechanisms of congenital myasthenic syndromes
Yazar:: Webster, R
Baskı/Yayın Bilgisi: (2018)

Effect of β2-adrenergic receptor agonists on neurotransmission and neuromuscular junction structure in congenital myasthenic syndromes
Yazar:: Vanhaesebrouck, A
Baskı/Yayın Bilgisi: (2018)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
Yazar:: Finlayson, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
Yazar:: Finlayson, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
Yazar:: Finlayson, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
Yazar:: Kinali, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Congenital myasthenic syndrome caused by mutations in DPAGT.
Yazar:: Klein, A, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
Yazar:: Chaouch, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Congenital myasthenic syndromes: Report of 7 Chile
Yazar:: Kleinsteuber, K, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
Yazar:: Spillane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
Yazar:: Belaya, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Congenital Myasthenic Syndromes
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (1994-01-01)

Therapy of myasthenic syndrome
Yazar:: Palace, J
Baskı/Yayın Bilgisi: (2012)

Congenital myasthenic syndromes
Yazar:: Josef Finsterer
Baskı/Yayın Bilgisi: (2019-02-01)

Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure
Yazar:: Rodríguez Cruz, PM, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Congenital Myasthenic Syndrome
Yazar:: WANG Wenqing, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

New diagnosis in Chilean population: congenital myasthenic syndromes
Yazar:: Kleinsteuber, K, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
Yazar:: Yamanashi, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2008)